Pierre Kyme - 09 Mar 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Issuer symbol
ARMP
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 21:18:19 UTC
Previous filing
25 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kyme Pierre Chief Business Officer 5005 MCCONNELL AVENUE, LOS ANGELES /s/ Pierre Kyme 11 Mar 2026 0002028892

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award +183,142 $0.000000* 183,142 09 Mar 2026 Common Stock 183,142 $11.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date.